Publications by authors named "Eun Bin Cho"

Article Synopsis
  • Researchers studied the quality of life (QOL) of patients with a condition called MOGAD and compared it to another condition called AQP4-IgG positive NMOSD.
  • They found that the overall QOL was similar between both groups, but many patients in both groups struggled with sleep, pain, and feelings of sadness.
  • The study suggests that both conditions need more focus on improving sleep and mental health to help patients feel better overall.
View Article and Find Full Text PDF
Article Synopsis
  • Neuromyelitis optica spectrum disorder (NMOSD) is a central nervous system disease that differs from multiple sclerosis by the presence of anti-aquaporin 4 antibodies (AQP4-ab) and occasionally other non-organ-specific autoantibodies.
  • A study involving 158 NMOSD patients collected data on various autoantibodies and analyzed their impact on clinical characteristics and disability levels.
  • Results indicated that the rheumatoid factor (RF) was significantly associated with higher disability levels; RF, age at onset, and annual relapse rate (ARR) emerged as key predictors for severe disability in NMOSD patients.
View Article and Find Full Text PDF

Depression is frequently reported in amyotrophic lateral sclerosis (ALS) due to the disastrous prognosis of progressive motor impairment, but the risk of depression in ALS is still unclear. Therefore, we investigated the risk of depression in ALS and analyzed the effect of ALS-related physical disability on the risk of developing depression using the Korean National Health Insurance Service (KNHIS) database. A total of 2241 ALS patients, as defined by the International Classification Diseases (ICD, G12.

View Article and Find Full Text PDF

Background And Purpose: Fatigue is common in demyelinating disorders of the central nervous system (CNS), including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). We aimed to validate the usefulness of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and the Fatigue Severity Scale (FSS) relative to the Korean version of the Modified Fatigue Impact Scale (MFIS-K) in Korean patients with MS, NMOSD, and MOGAD.

Methods: There were 294 patients with MS (=120), NMOSD (=103), or MOGAD (=71) enrolled in a prospective demyelinating CNS registry.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the risk of migraine in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) within a Korean population.
  • It analyzed claims data from 1,492 MS patients and 1,551 NMOSD patients, comparing their migraine risk against matched controls, excluding patients under 20 and those with prior migraines.
  • Findings indicate that MS patients have a higher risk of migraine compared to controls, while NMOSD patients show no significant difference; also, comorbidities don't significantly affect migraine risk in either group.
View Article and Find Full Text PDF

Background: Myelin oligodendrocyte glycoprotein antibody (MOG) immunoglobulin G (IgG)-associated disease (MOGAD) has clinical and pathophysiological features that are similar to but distinct from those of aquaporin-4 antibody (AQP4-IgG)-positive neuromyelitis optica spectrum disorders (AQP4-NMOSD). MOG-IgG and AQP4-IgG, mostly of the IgG1 subtype, can both activate the complement system. Therefore, we investigated whether the levels of serum complement components, regulators, and activation products differ between MOGAD and AQP4-NMOSD, and if complement analytes can be utilized to differentiate between these diseases.

View Article and Find Full Text PDF

Background: We investigated the risks of depression/anxiety in patients with multiple sclerosis (pwMS) or patients with neuromyelitis optica spectrum disorder (pwNMOSD).

Objectives: MS/NMOSD cohorts were collected from Korean National Health Insurance Service, using the International Classification of Diseases-10th and information on Rare Intractable Disease program. Patients who were younger than 20 years, had a previous depression/anxiety, or died in the index year were excluded.

View Article and Find Full Text PDF

Background And Objectives: An association has been suggested between premorbid type 2 diabetes mellitus (T2DM) and the risk of multiple sclerosis (MS). However, little is known about the risk of developing T2DM in MS and neuromyelitis optica spectrum disorder (NMOSD). This study aimed to determine the T2DM risk in patients with MS and NMSOD.

View Article and Find Full Text PDF

Background: The risk of myocardial infarction (MI), the major form of CVD, in amyotrophic lateral sclerosis (ALS) is currently unknown. We investigated the risk of MI in ALS and analyzed the effect of ALS-related physical disability on the risk of MI using the Korean National Health Insurance Service database.

Methods: A total of 659 ALS patients and 10,927 non-ALS participants were finally selected between January 1, 2011, and December 31, 2015.

View Article and Find Full Text PDF

Introduction: Cognitive impairment is a common feature of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). However, there is a lack of population-based study of dementia risk in these disorders. In the present study, the risk of dementia in MS and NMOSD patients in Republic of Korea was estimated.

View Article and Find Full Text PDF

Purpose: Interest in fractures in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has considerably increased in the last decade. However, few studies have compared the incidence of fractures between patients with MS and NMOSD using a nationwide database. This study aimed to evaluate the differences in the risk of fracture between patients with NMOSD and MS compared to that in healthy controls using cohort data from a Korean nationwide database.

View Article and Find Full Text PDF

Unlabelled: Fracture risk was elevated in Parkinson's disease (PD) patients compared with controls in this nationwide study. Among PD patients, the risk of fracture increased linearly with PD severity, whereas no difference in fracture risk was observed according to PD duration.

Introduction: Parkinson's disease (PD) is reported to be associated with a high risk of fractures.

View Article and Find Full Text PDF

Background: People with multiple sclerosis (MS) are more likely to develop stroke than those without. However, little is known about the association between neuromyelitis optica spectrum disorder (NMOSD) and the risk of stroke. We aimed to estimate the risk of stroke in patients with MS and NMOSD in South Korea.

View Article and Find Full Text PDF

Background: Neurodegeneration is associated with pathogenesis of both multiple sclerosis (MS) and neuromyelitis optica (NMOSD). Parkinson's disease (PD) is a representative neurodegenerative disease, however, whether MS or NMOSD is associated with risk of PD is not known.

Methods: MS and NMOSD cohorts were collected from the Korean National Health Insurance Service between 1 January 2010 and 31 December 2017, using International Classification of Diseases 10th revision diagnosis codes and information in the Rare Intractable Disease management programme.

View Article and Find Full Text PDF

Background: The link between neuromyelitis optica spectrum disorder (NMOSD) and cardiovascular disease is currently unclear.

Objective: To determine the acute myocardial infarction (MI) risk in patients with MS and NMOSD.

Methods: This study analyzed the Korean National Health Insurance Service database between January 2010 and December 2017.

View Article and Find Full Text PDF

Background: In the present study, it was investigated whether autonomic dysfunction could predict prognosis in light-chain (AL) amyloidosis patients.

Patients And Methods: Seventy-two patients with biopsy-proven AL amyloidosis were included and underwent an autonomic function test (AFT) between January 2016 and June 2019. Autonomic failure was evaluated using the Composite Autonomic Severity Score (CASS).

View Article and Find Full Text PDF

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are two representative chronic inflammatory demyelinating disorders of the central nervous system. We aimed to determine and compare the alterations of white matter (WM) connectivity between MS, NMOSD, and healthy controls (HC). This study included 68 patients with relapsing-remitting MS, 50 with NMOSD, and 26 HC.

View Article and Find Full Text PDF

Although fatigue is a major symptom in patients with neuromyelitis optica spectrum disorder (NMOSD), the underlying mechanism remains unclear. We explored the relationship between subcortical structures and fatigue severity to identify neural substrates of fatigue in NMOSD. Clinical characteristics with brain magnetic resonance imaging were evaluated in forty patients with NMOSD.

View Article and Find Full Text PDF

Background: Clear associations have been found between vitamin D deficiency and several autoimmune diseases including multiple sclerosis (MS). However, the benefits of vitamin D supplementation on disease management remain a matter of debate.

Objective And Methods: Patients with MS (=12) and neuromyelitis optica spectrum disorder (NMOSD; =12) were enrolled along with 15 healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 586 participants, 36 (6.1%) tested positive for anti-MOG antibodies, while 185 (31.6%) tested positive for anti-AQP4 antibodies.
  • * The study revealed that MOG antibody prevalence is about five times lower than AQP4 antibody prevalence among these adults, with no individuals showing both antibodies simultaneously.
View Article and Find Full Text PDF

Background: Altered lipid metabolism is a feature of systemic autoimmune diseases. Dyslipidemia is associated with the disease activity and progression in patients with multiple sclerosis. However, in neuromyelitis optica spectrum disorder (NMOSD), changes in the lipid profile and the associations between specific lipid levels and disease activity/disability are unknown.

View Article and Find Full Text PDF

Background And Purpose: Diagnosing small-fiber neuropathy (SFN) is challenging because there is no gold-standard test and few diagnostic tests. This study investigated the clinical symptom profile and its associations with the results of quantitative sensory testing (QST) and the quantitative sudomotor axon reflex test (QSART) as well as the quality of life (QOL) in patients with clinically suspected SFN.

Methods: This study involved 63 patients with clinically suspected length-dependent SFN.

View Article and Find Full Text PDF